All Updates

All Updates

icon
Filter
Product updates
Cybin announces streamlined training program for facilitators
Psychedelic Medicine
Jul 12, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Psychedelic Medicine

Psychedelic Medicine

Jul 12, 2023

Cybin announces streamlined training program for facilitators

Product updates

  • Canadian psychedelic biotech company Cybin announced the development of EMBARKCT, a streamlined version of its EMBARK Training Program.

  • EMBARKCT is a training program that enables Cybin to screen, qualify, train, and certify facilitators for larger clinical trials, providing support and in-person monitoring. The program focuses on future pivotal studies of Cybin's lead candidates, CYB003 and CYB004, which aim to treat major depressive disorder and generalized anxiety disorder, respectively. 

  • The program builds upon the foundation laid by EMBARK Open Access (EMBARK OA), a free online training course for psychedelic facilitation. EMBARKCT is designed to scale up and improve accessibility to training resources, potentially increasing the number of facilitators participating in Cybin-sponsored clinical trials.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.